This randomized clinical trial assesses whether home-based exercise, weight loss, or a combination of home-based exercise and weight loss have an effect on breast cancer–related lymphedema outcomes among overweight breast cancer survivors.
This database study assesses the frequency of race reporting and proportional race representation in trials that support FDA oncology drug approvals.
This cohort study analyzes the medical records of 47 721 patients with various cancer types with POLE/POLD1 mutations to evaluate whether the mutations were associated with immunotherapy outcomes.
In this essay, the author reflects on lessons learned from a patient with metastatic lung cancer who wanted to have a baby.
This phase 2 multicenter randomized clinical trial including 88 patients compares progression-free survival, and secondarily overall survival, overall response rate, and adverse events, in patients with stage 4 EGFR-mutant non–small cell lung cancer treated with erlotinib plus bevacizumab vs erlotinib alone.
This secondary analysis of the Stockholm Tamoxifen (STO-3) clinical trial, which was conducted from 1976 to 1990, assessed the long-term survival associated with tamoxifen therapy in postmenopausal patients with luminal A or B breast cancer tumor subtypes.
This database study assesses the number of female lead investigators of randomized clinical trials registered in ClinicalTrials.gov.
This Viewpoint examines the components and benefits of a systems approach to meeting the challenges of global oncology.
This database study compared cancer-specific mortality in HIV-infected vs HIV-uninfected elderly patients after adjusting data for receipt of specific cancer treatments.
This validation study assesses the clinical validity of molecular relapse detection with circulating tumor DNA analysis in early-stage breast cancer.
This Viewpoint describes the barriers to accessing beneficial palliative care under the current Medicare reimbursement structure for hospice.
Create a personal account or sign in to: